project id: TCGA-TGCT; case submitter id: TCGA-2G-AALP; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.47; rna integrity number: 7.3; age at index: 43; days to birth: -15977; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1964; age at diagnosis: 15977; ajcc clinical m: M1; ajcc clinical n: N1; ajcc clinical stage: Stage IIIB; ajcc clinical t: T1; ajcc pathologic m: M1; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T1; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2645.0; icd 10 code: C62.90; last known disease status: not reported; morphology: 9085/3; primary diagnosis: Mixed germ cell tumor; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Testis, NOS; synchronous malignancy: No; tissue or organ of origin: Testis, NOS; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2373; days to sample procurement: 0; initial weight: 300.0; portion submitter id: TCGA-2G-AALP-01A-12; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 50.0; percent stromal cells: 0.0; percent tumor cells: 50.0; percent tumor nuclei: 60.0;